액면가가 다시 20대로 돌아왔습니다만ㅋㅋㅋㅋ

앞으로 100세 넘은 노인들은 이거 시술 다 받을 듯ㅋㅋㅋㅋ

참으로다가 좋은 세상이에욬ㅋㅋ

CRISPR-Cas9

CRISPR-Cas9 is highly versatile and can be used to edit genes in various types of somatic cells after birth. This technology has been employed in clinical trials to treat conditions like sickle cell anemia and certain types of cancer by editing genes in the patient’s own cells. For example, in some therapies, a patient's blood cells are extracted, edited outside the body, and then reintroduced into the patient.

TALENs (Transcription Activator-Like Effector Nucleases)

TALENs can also be used for gene editing in somatic cells. They are capable of targeting and modifying specific genes in mature cells. TALENs have been used in research and therapeutic contexts, such as in editing T cells for cancer immunotherapy.

ZFNs (Zinc Finger Nucleases)

ZFNs are another option for editing genes in somatic cells. They have been used in clinical settings, notably for treating HIV by editing the CCR5 gene in T cells to make them resistant to the virus.

Base Editors

Base Editors offer a more refined method of gene editing that can change single DNA bases without making double-strand breaks. This technology is suitable for somatic cell editing and has been explored for correcting point mutations in various genetic diseases.

Prime Editing

Prime Editing is a newer technology that allows for precise editing without double-strand breaks and can perform a wider range of genetic edits than base editors. It is also applicable for editing somatic cells and holds promise for treating genetic disorders after birth.

Delivery Methods for Somatic Cell Gene Editing

Effective delivery of these gene editing tools into the target somatic cells is crucial. Common delivery methods include:

• Viral Vectors: Modified viruses (such as adeno-associated viruses) are used to deliver the gene editing components into the cells.
• Lipid Nanoparticles: These can encapsulate the gene editing tools and deliver them into cells.
• Electroporation: A technique where an electric field is used to increase the permeability of the cell membrane, allowing the gene editing components to enter.

Current Applications and Research

Gene editing in somatic cells has several ongoing and potential applications:

• Blood Disorders: Treating sickle cell anemia and beta-thalassemia by editing hematopoietic stem cells.
• Cancer Therapy: Engineering T cells to better recognize and kill cancer cells (e.g., CAR-T cell therapy).
• Muscular Dystrophy: Editing muscle cells to correct mutations causing diseases like Duchenne muscular dystrophy.
• Infectious Diseases: Editing immune cells to resist infections, such as making T cells resistant to HIV.

These technologies, particularly CRISPR-Cas9, base editors, and prime editors, are at the forefront of gene editing research and clinical applications aimed at treating diseases after birth.